Measurement of Upsilon production in 7 TeV pp collisions at ATLAS

Using 1.8 fb(-1) of pp collisions at a center- of- mass energy of 7 TeV recorded by the ATLAS detector at the Large Hadron Collider, we present measurements of the production cross sections of Upsilon(1S,2S,3S) mesons. Upsilon mesons are reconstructed using the dimuon decay mode. Total production cross sections for p(T) < 70 GeV and in the rapidity interval vertical bar y(Upsilon)vertical bar < 2. 25 are measured to be, 8.01 +/- 0.02 +/- 0.36 +/- 0.31 nb, 2.05 +/- 0.01 +/- 0.12 +/- 0.08 nb, and 0.92 +/- 0.01 +/- 0.07 +/- 0.04 nb, respectively, with uncertainties separated into statistical, systematic, and luminosity measurement effects. In addition, differential cross section times dimuon branching fractions for Upsilon(1S), Upsilon(2S), and Upsilon(3S) as a function of Upsilon transverse momentum pT and rapidity are presented. These cross sections are obtained assuming unpolarized production. If the production polarization is fully transverse or longitudinal with no azimuthal dependence in the helicity frame, the cross section may vary by approximately +/- 20%. If a nontrivial azimuthal dependence is considered, integrated cross sections may be significantly enhanced by a factor of 2 or more. We compare our results to several theoretical models of Upsilon meson production, finding that none provide an accurate description of our data over the full range of Upsilon transverse momenta accessible with this data set.

First report about the mode of action of combined butafosfan and cyanocobalamin on hepatic metabolism in nonketotic early lactating cows

The primary aim was to investigate the effect of combined butafosfan and cyanocobalamin on liver metabolism in early lactating cows through mRNA expression measurements of genes encoding 31 enzymes and transport proteins of major metabolic processes in the liver using 16 multiparous early lactating dairy cows. The treatments included i.v. injection of 10 mL/100 kg of body weight combined butafosfan and cyanocobalamin (TG, n = 8) on 3 d consecutively at 25 +/- 3 d in milk or injection with physiological saline solution similarly applied (CG, n = 8). Results include a higher daily milk production for TG cows (41.1 +/- 0.9 kg, mean +/- SEM) compared with CG cows (39.5 +/- 0.7 kg). In plasma, the concentration of inorganic phosphorus was lower in the TG cows (1.25 +/- 0.08 mmol/L) after the treatment than in the CG cows (1.33 +/- 0.07 mmol/L). The plasma beta-hydroxybutyrate concentration was 0.65 +/- 0.13 mmol/L for all cows before the treatment, and remained unaffected post treatment. The unique result was that in the liver, the mRNA abundance of acyl-coenzyme A synthetase long-chain family member 1, involved in fatty acid oxidation and biosynthesis, was lower across time points after the treatment for TG compared with CG cows (17.5 +/- 0.15 versus 18.1 +/- 0.24 cycle threshold, log(2), respectively). In conclusion, certain effects of combined butafosfan and cyanocobalamin were observed on mRNA abundance of a gene in the liver of nonketotic early lactating cows.

Measurement of the production cross-section of ψ → J/ψ ( o μ+ μ) π π in pp collisions at √s = 7 TeV at ATLAS

The prompt and non-prompt production cross-sections for ψ(2S) mesons are measured using 2.1 fb−1 of pp collision data at a centre-of-mass energy of 7TeV recorded by the ATLAS experiment at the LHC. The measurement exploits the ψ(2S) → J/ψ (→μ+μ−)π+π− decay mode, and probes ψ(2S) mesons with transverse momenta in the range10 ≤ pT < 100 GeV and rapidity |y| < 2.0. The results are compared to other measurements of ψ(2S) production at the LHC and to various theoretical models for prompt and non-prompt quarkonium production.